The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 128 (2) , 189-201
- https://doi.org/10.1016/0022-1759(90)90210-m
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Structural basis of antigen recognition by T lymphocytes. Implications for vaccines.Journal of Clinical Investigation, 1988
- Efficient Propagation and Cloning of Human T Cells in the Absence of Antigen by Means of OKT3, Interleukin 2, and Antigen‐Presenting CellsScandinavian Journal of Immunology, 1988
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Epstein-Barr virus-transformed lymphoblastoid cell lines as antigen-presenting cells and “Augmenting” cells for human CMV-specific Th clonesCellular Immunology, 1987
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987
- Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.The Journal of Experimental Medicine, 1986
- The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptidesCell, 1986
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicityNature, 1979